Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS

(NOVN)
  Rapport  
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
Fonds positionnés sur NOVARTIS
NomPEA1er Jan5 ansNotationPosition
BNY Mellon Glbl Rl Ret (EUR) X AccNON6.00%16.00%59.52M EUR
BNY Mellon Global Real Ret (GBP) X AccNON8.00%8.00%NC1.27M GBP
Capital Group Eurp Gr&Inc Fd(LUX)ZAccSGDNON12.00%25.00%18.32M EUR
CPR Invest Europe Spec Situations I AccNON10.00%0.00%NC1.1M EUR
DPAM Capital B Equities Europe Idx F CapNON13.00%23.00%15.62M EUR
DWS Invest II Eurp Top Div LDNON9.00%17.00%10.64M EUR
DWS Top Dividende LDNON11.00%45.00%117.08M EUR
FP CRUX European Special Sit I Acc GBPNON14.00%45.00%11.4M GBP
GAM Star Continental Eurp Eq EUR AccNON16.00%31.00%45.44M EUR
GAM Star European Equity EUR AccNON16.00%28.00%8.12M EUR
Invesco Continental Eur Eq A EUR ADNON7.00%12.00%NC1.69M EUR
Invesco Global Equity Income Z USD AccNON11.00%38.00%67.5M USD
Invesco Pan European Eq Inc A EUR AccNON8.00%16.00%1.17M EUR
Invesco Pan European Hi Inc A EUR AccNON6.00%15.00%74.84M EUR
Investec GSF Glb Endur Eq C Inc-2IRDZARHNON14.00%0.00%NC16.53M ZAR
Investec GSF Glb Qual Eq Inc S Inc USDNON16.00%79.00%7.85M USD
IShares Europe Equity Index (LU) X2 EURNON14.00%28.00%8.31M EUR
IShares Europe ex-UK Idx (IE) Flex Acc€NON14.00%32.00%75.77M EUR
M&G (Lux) Eurp Strat Val CI EUR AccNON8.00%21.00%NC67.79M EUR
M&G (Lux) Glb Dividend A EUR AccNON12.00%36.00%NC90M EUR
M&G European Index Tracker Euro A AccNON14.00%30.00%2.86M EUR
M&G European Select Euro A AccNON15.00%25.00%1.88M EUR
Neuberger Berman Sysmc Glb Eq ERU M AccNON8.00%0.00%NC0.29M EUR
Nordea 1 - European Focus Equity BP EURNON17.00%0.00%1.11M EUR
Pictet-Europe Index I EURNON13.00%25.00%135.84M EUR
Schroder ISF Global Eq Alp C Acc USDNON13.00%57.00%33.11M USD
Schroder ISF Global Eq I Acc USDNON15.00%72.00%6.9M USD
Schroder ISF QEP Glb ActvVal I Acc USDNON9.00%42.00%10M USD
Schroder ISF QEP Glbl Qual I Acc USDNON14.00%67.00%8.29M USD
Schroder ISF QEP Glbl Val Pl A Acc USDNON5.00%24.00%0.76M USD
Schroder ISF Swiss Eq Opports A Acc CHFNON13.00%26.00%3.24M CHF
Schroder ISF Swiss Equity A Acc CHFNON14.00%36.00%0.56M CHF
SEB LI Schroder Intl Sel Global Eq USDNON14.00%56.00%NC6.9M USD
Swiss Life (LUX) Pf Glb Gr (CHF) RNON12.00%28.00%117.08M CHF
Swisscanto (LU) PF Rspnb Ambt(CHF)AT CHFNON8.00%27.00%1.07M CHF
Swisscanto (LU) PF Rspnb Ambt(EUR)AT EURNON7.00%25.00%0.74M EUR
Swisscanto (LU) PF Rspnb Bal(CHF) AA CHFNON6.00%23.00%117.08M CHF
Swisscanto (LU) PF Rspnb Foc(CHF) AT CHFNON9.00%36.00%0.74M CHF
Swisscanto (LU) PF Rspnb Sel(CHF) AA CHFNON5.00%18.00%20.62M CHF
UBAM Swiss Equity IC CHFNON19.00%55.00%117.08M CHF
UBS (Lux) KSS Glbl Allc (EUR) PNON8.00%10.00%3.54M EUR
UBS (Lux) SF Equity (CHF) P-accNON11.00%28.00%11.54M CHF



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Graphique NOVARTIS
Durée : Période :
Novartis : Graphique analyse technique Novartis | NOVN | CH0012005267 | Zone bourse
Evolution du Compte de Résultat
Consensus
Vente
Achat
Recommandation moyenne ACCUMULER
Nombre d'Analystes 27
Objectif de cours Moyen 89,7 $
Ecart / Objectif Moyen 3,0%
Révisions de BNA
Secteur et Concurrence
Var. 1janvCapitalisation (M$)
NOVARTIS17.44%219 832
JOHNSON & JOHNSON8.32%368 655
PFIZER-3.96%233 239
ROCHE HOLDING LTD.11.42%233 096
MERCK AND COMPANY6.23%208 984
ABBVIE-13.16%118 355